Initial therapeutic trial of new drugs in lung cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight; D002283:Carcinoma, Bronchogenic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D011247:Pregnancy; D011379:Prognosis; D012107:Research Design; D013997:Time Factors
D000970:Antineoplastic Agents; D003520:Cyclophosphamide